AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products in Bermuda, the United States, and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers professional insurance products that cover directors' and officers' liability, errors and omissions, employment practices, fiduciary, crime, professional indemnity, medical malpractice, and other financial insurance related coverages for commercial enterprises, financial institutions, not-for-profit organizations, and other professional service providers; and property insurance products for commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism. This segment also provides marine and aviation insurance services for offshore energy, offshore renewable energy, cargo, liability, including kidnap and ransom, fine art, specie, and hull war, hull and liability, and specific war coverage for passenger airlines, cargo operations, general aviation operations, airports, aviation authorities, security firms, and  product manufacturers; personal accident, travel insurance, specialty health products for employer and affinity groups, and pet insurance products; and liability, cyber, and credit and political risk insurance services. The Reinsurance segment offers agriculture, marine and aviation, catastrophe, accidental and health, credit and surety, motor, professional, travel, life, engineering, property, and liability reinsurance products. AXIS Capital Holdings Limited was founded in 2001 and is headquartered in Pembroke, Bermuda.

AXIS Capital Holdings Limited

Accsys Technologies ( ($GB:AXS) ) has shared an announcement. Accsys Technologies PLC said shareholders approved all resolutions at its annual gene...

Accsys Investors Approve All AGM Resolutions and Switch Auditor to Deloitte

Axsome Therapeutics received a Buy rating and a $285.00 price target from Truist Financial analyst Srikripa Devarakonda today. According to TipRank...

Axsome Therapeutics (AXSM) Has a New Rating from Truist Financial

H.C. Wainwright analyst Ram Selvaraju maintained a Buy rating on Axsome Therapeutics today and set a price target of $290.00. Selvaraju covers the ...

H.C. Wainwright Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)

In a report released yesterday, Yaron Kinar from Mizuho Securities maintained a Buy rating on Axis Capital, with a price target of $118.00. The com...

Mizuho Securities Remains a Buy on Axis Capital (AXS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Scholar Rock Holding (SRRK), Axsome Therapeutics (...

Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK), Axsome Therapeutics (AXSM) and Ionis Pharmaceuticals (IONS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AXS	$94.45	-0.29%	441.74K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AXS	$94.45	-0.3%	441.74K
3
4
5
6

AXS

Get AXIS Capital Holdings Limited Data in Excel

Get AXIS Capital Holdings Limited Data in Excel